Cost-Effectiveness of Axicabtagene Ciloleucel Versus Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma in the USOlalekan O. Oluwole,Markqayne D Ray, Richard Zur, Aurelia Little,Cheryl Ferrufino, Brett Doble,Anik R Patel,Pinar BilirBlood(2023)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要